Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in IndiaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Reliance Life Sciences with 4 drug recalls and 1 warning letter. The most recent is a warning letter dated Aug 18, 2026: Warning letter: Data integrity, Aseptic processing, Sterility assurance.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Aug 18, 2026 | Warning letter: Data integrity, Aseptic processing, Sterility assuranceCDER | Warning letters |
| Jun 24, 2026 | Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset TheClass II · Lack of Sterility Assurance | Drug recalls |
| Jun 24, 2026 | Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset TherapeuticClass II · Lack of Sterility Assurance | Drug recalls |
| Jun 24, 2026 | Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset TheClass II · Lack of Sterility Assurance | Drug recalls |
| Jun 24, 2026 | Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured forClass II · Lack of Sterility Assurance | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
